Precision Biosciences (DTIL) EBIAT (2018 - 2025)
Historic EBIAT for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$21.8 million.
- Precision Biosciences' EBIAT fell 3255.4% to -$21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.6 million, marking a year-over-year decrease of 106952.34%. This contributed to the annual value of $7.2 million for FY2024, which is 11168.81% up from last year.
- As of Q3 2025, Precision Biosciences' EBIAT stood at -$21.8 million, which was down 3255.4% from -$23.5 million recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' EBIAT registered a high of $32.7 million during Q2 2024, and its lowest value of -$31.0 million during Q2 2022.
- For the 5-year period, Precision Biosciences' EBIAT averaged around -$14.0 million, with its median value being -$18.7 million (2021).
- Per our database at Business Quant, Precision Biosciences' EBIAT soared by 37541.0% in 2024 and then tumbled by 33946.2% in 2025.
- Over the past 5 years, Precision Biosciences' EBIAT (Quarter) stood at -$22.3 million in 2021, then decreased by 27.81% to -$28.5 million in 2022, then skyrocketed by 42.82% to -$16.3 million in 2023, then decreased by 8.94% to -$17.7 million in 2024, then dropped by 22.69% to -$21.8 million in 2025.
- Its last three reported values are -$21.8 million in Q3 2025, -$23.5 million for Q2 2025, and -$20.6 million during Q1 2025.